نتائج البحث - "Huennemeyer, Andreas"

1

مؤتمر

32 Safety, pharmacokinetics and pharmacodynamics of BI 705564, a covalent inhibitor of brutons tyrosine kinase in phase 1 clinical trials in healthy volunteers

المؤلفون: Litzenburger, Tobias, Müller, Fabian, Schultz, Armin, Klein, Elliott, Ramanujam, Meera, Wu, Jing, Wiebe, Sabrina, Benediktus, Ewald, Hui, Jianan, Li, Xiujiang, Flack, Mary, Padula, Steven J, Visvanathan, Sudha, Steffgen, Jürgen, Hünnemeyer, Andreas

المصدر: Abstracts

الإتاحة: https://doi.org/10.1136/lupus-2019-lsm.32Test

View record in BASE

2

دورية أكاديمية

Safety, pharmacokinetics and pharmacodynamics of BI 705564, a highly selective, covalent inhibitor of Bruton's tyrosine kinase, in Phase I clinical trials in healthy volunteers

المؤلفون: Litzenburger, Tobias, Steffgen, Jürgen, Benediktus, Ewald, Müller, Fabian, Schultz, Armin, Klein, Elliott, Ramanujam, Meera, Harcken, Christian, Gupta, Alpana, Wu, Jing, Wiebe, Sabrina, Li, Xiujiang, Flack, Mary, Padula, Steven J., Visvanathan, Sudha, Hünnemeyer, Andreas, Hui, Jianan

المساهمون: Boehringer Ingelheim

المصدر: British Journal of Clinical Pharmacology ; volume 87, issue 4, page 1824-1838 ; ISSN 0306-5251 1365-2125

الإتاحة: https://doi.org/10.1111/bcp.14571Test

View record in BASE

3

دورية أكاديمية

Population Pharmacokinetic Modelling of Roflumilast and Roflumilast N-Oxide by Total Phosphodiesterase-4 Inhibitory Activity and Development of a Population Pharmacodynamic-Adverse Event Model

المؤلفون: Lahu, Gezim, Hünnemeyer, Andreas, Diletti, Edgar, Elmlinger, Martin, Ruth, Peter, Zech, Karl, McCracken, Nigel, Facius, Axel

المصدر: Clinical Pharmacokinetics ; volume 49, issue 9, page 589-606 ; ISSN 0312-5963

مصطلحات موضوعية: Pharmacology (medical), Pharmacology

الإتاحة: https://doi.org/10.2165/11536600-000000000-00000Test

View record in BASE

4

دورية أكاديمية

Midazolam microdosing applied in early clinical development for drug–drug interaction assessment.

المؤلفون: Wiebe, Sabrina T.^1,2 (AUTHOR), Huennemeyer, Andreas² (AUTHOR), Kadus, Werner² (AUTHOR), Goettel, Markus² (AUTHOR), Jambrecina, Alen³ (AUTHOR), Schultz, Armin⁴ (AUTHOR), Vinisko, Richard⁵ (AUTHOR), Schlieker, Laura⁶ (AUTHOR), Herich, Lena⁶ (AUTHOR), Mikus, Gerd¹ (AUTHOR) gerd.mikus@med.uni-heidelberg.de

المصدر: British Journal of Clinical Pharmacology. Jan2021, Vol. 87 Issue 1, p178-188. 11p.

مصطلحات موضوعية: *MIDAZOLAM, *ANALYSIS of variance, *DATA analysis

النص الكامل

5

دورية أكاديمية

Effect of Steady-State Enoxacin on Single-Dose Pharmacokinetics of Roflumilast and Roflumilast N-Oxide

المؤلفون: Lahu, Gezim, Nassr, Nassr, Herzog, Rolf, Elmlinger, Martin, Ruth, Peter, Hinder, Markus, Huennemeyer, Andreas

المصدر: The Journal of Clinical Pharmacology ; volume 51, issue 4, page 586-593 ; ISSN 0091-2700

الإتاحة: https://doi.org/10.1177/0091270010370590Test

View record in BASE

6

دورية أكاديمية

CHRONOPHARMACOLOGY OF ROFLUMILAST: A COMPARATIVE PHARMACOKINETIC STUDY OF MORNING VERSUS EVENING ADMINISTRATION IN HEALTHY ADULTS

المؤلفون: Bethke, Thomas D., Huennemeyer, Andreas, Lahu, Gezim, Lemmer, Björn

المصدر: Chronobiology International ; volume 27, issue 9-10, page 1843-1853 ; ISSN 0742-0528 1525-6073

الإتاحة: https://doi.org/10.3109/07420528.2010.520398Test

View record in BASE

7

دورية أكاديمية

Effects of rifampicin on the pharmacokinetics of roflumilast and roflumilast N‐oxide in healthy subjects

المؤلفون: Nassr, Nassr, Huennemeyer, Andreas, Herzog, Rolf, Von Richter, Oliver, Hermann, Robert, Koch, Manuela, Duffy, Kevin, Zech, Karl, Lahu, Gezim

المصدر: British Journal of Clinical Pharmacology ; volume 68, issue 4, page 580-587 ; ISSN 0306-5251 1365-2125

الإتاحة: https://doi.org/10.1111/j.1365-2125.2009.03478.xTest

View record in BASE

8

دورية أكاديمية

The Targeted Oral, Once‐Daily Phosphodiesterase 4 Inhibitor Roflumilast and the Leukotriene Receptor Antagonist Montelukast Do Not Exhibit Significant Pharmacokinetic Interactions

المؤلفون: Böhmer, Gabriele M., Nassr, Nassr, Wenger, Marcus, Hünnemeyer, Andreas, Lahu, Gezim, Templin, Silke, Gleiter, Christoph H., Hermann, Robert

المصدر: The Journal of Clinical Pharmacology ; volume 49, issue 4, page 389-397 ; ISSN 0091-2700 1552-4604

الإتاحة: https://doi.org/10.1177/0091270008330980Test

View record in BASE

9

دورية أكاديمية

Effect of Single and Repeated Doses of Ketoconazole on the Pharmacokinetics of Roflumilast and Roflumilast N‐Oxide

المؤلفون: Lahu, Gezim, Huennemeyer, Andreas, von Richter, Oliver, Hermann, Robert, Herzog, Rolf, McCracken, Nigel, Zech, Karl

المصدر: The Journal of Clinical Pharmacology ; volume 48, issue 11, page 1339-1349 ; ISSN 0091-2700 1552-4604

الإتاحة: https://doi.org/10.1177/0091270008321941Test

View record in BASE

10

دورية أكاديمية

Magnesium Hydroxide/Aluminium Hydroxide‐Containing Antacid Does Not Affect the Pharmacokinetics of the Targeted Phosphodiesterase 4 Inhibitor Roflumilast

المؤلفون: Nassr, Nassr, Lahu, Gezim, Hünnemeyer, Andreas, von Richter, Oliver, Knoerzer, Dietrich, Reutter, Felix, Zech, Karl, Hermann, Robert

المصدر: The Journal of Clinical Pharmacology ; volume 47, issue 5, page 660-666 ; ISSN 0091-2700 1552-4604

الإتاحة: https://doi.org/10.1177/0091270006297920Test

View record in BASE

تنقيح النتائج